Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 447.50
Bid: 440.00
Ask: 455.00
Change: -2.50 (-0.56%)
Spread: 15.00 (3.409%)
Open: 450.00
High: 450.00
Low: 447.50
Prev. Close: 450.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK and EU regulatory approval update

26 Feb 2024 07:00

RNS Number : 3374E
Tristel PLC
26 February 2024
 

TRISTEL plc

("Tristel", the "Company", or the "Group")

 

UK and EU regulatory approval update for surface disinfection system

 

Sustainable alternative to commonly used pre-wetted plastic wipes to become available in Europe

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products utilising proprietary chlorine dioxide technology, announces that all reviews under the Medical Devices Regulation 2002 ("UK MDR") and the European Union Medical Device Regulation 2017/745 ("EU MDR") for approval of the Company's TANK ClO? Sporicidal Disinfectant system have been successfully concluded and a positive recommendation for UKCA and MDR certification has been made.

 

The TANK system and accompanying capsules are the newest additions to the Cache range, which provides sporicidal surface disinfection in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.

 

Following MDR approvals Tristel will be able to accelerate sales activity for this product throughout Europe and across geographies that recognise the high standard of safety and quality demonstrated by products conforming to the new EU MDR. The Directors believe that approval, will give Tristel the opportunity to deliver significant growth in sales of the Cache product range going forward, targeting a largely untapped sporicidal surface disinfection market. The Company expects to officially launch these latest products in Europe before the current financial year end on 30 June 2024.

 

For the year ended 30 June 2023 revenues from the Cache range totalled £3.3m, representing 9.2% of total annual turnover.

 

About TANK ClO? Sporicidal Disinfectant and the Cache range (https://thecachecollection.com)

TANK ClO? Sporicidal Disinfectant is a storage and distribution system powered by ClO? sporicidal disinfectant capsules. One TANK ClO? Sporicidal Disinfectant capsule makes 10 litres of sporicidal solution, which is the same as 2,000 sporicidal wipes wetted with 5ml of liquid. Rather than relying on convenience products that do harm once they are disposed of, TANK uses plastic thoughtfully. The core components are reusable, and all the plastic items within the system are recyclable. Users can apply TANK ClO? Sporicidal Disinfectant working solution with a Doser, Foamer or Sprayer, and reduce plastic waste by pairing TANK working solution with any dry wipe.

 

 

The TANK ClO? Sporicidal Disinfectant system

 

 

The broader Cache product range for sporicidal surface disinfection

 

For further information on the TANK ClO? Sporicidal Disinfectant system please view the product brochure here:

https://thecachecollection.com/wp-content/uploads/2021/09/Mkt-Bro-1508-6-TANK-ClO2-Sporicidal-Brochure-EN.pdf

 

Paul Swinney, CEO of Tristel, commented: "Whilst our Cache product range is intended for environmental surfaces, many of the surfaces in a hospital setting are considered medical devices and so it is key for any disinfection products to comply with the new EU Medical Device Regulation. It is a very significant achievement to have concluded all reviews successfully and we expect to receive our recommendation for certification from our Notified Body very shortly. Conformity with MDR will allow us to apply CE marking to these new products and gives us the opportunity to deliver significant growth in sales of the Cache product range going forward."

 

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

www.investors.tristel.com

Liz Dixon, Chief Financial Officer

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Charlotte Edgar

Mob: 07884 664 686

Cavendish Capital Markets Ltd

Tel: 020 7220 0500

Geoff Nash / Charlie Beeson (Corporate Finance)

Sunila de Silva (ECM)

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries.

 

The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit: https://tristel.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGZGZZNFRGDZM
Date   Source Headline
6th Oct 20087:00 amRNSFinal Results
3rd Sep 20089:05 amRNSGrant of Patent
25th Jul 20087:00 amRNSTrading update & Notice of re
7th Jul 200810:55 amRNSDirector/PDMR Shareholding
1st Jul 20087:00 amRNSGrant of Patent
23rd Jun 20087:00 amRNSSupply and Distribution Agree
28th May 200811:32 amRNSDirector/PDMR Shareholding
2nd May 20087:00 amRNSDirector/PDMR Shareholding
4th Apr 20085:04 pmRNSCorrection -Board Appointment
4th Apr 20087:01 amRNSDirector/PDMR Shareholding
3rd Apr 20087:00 amRNSBoard Appointment
27th Mar 20089:26 amRNSDirector/PDMR Shareholding
12th Mar 20081:30 pmRNSIssue of Equity
3rd Mar 20087:01 amRNSNew supply agreement
3rd Mar 20087:00 amRNSInterim Results
7th Feb 20087:00 amRNSNotice of Results
6th Feb 20081:19 pmRNSRe. Tristel Italia srl
3rd Jan 20083:29 pmRNSGrant of patent
11th Dec 200711:42 amRNSAGM Statement
5th Nov 200712:38 pmRNSDirector/PDMR Shareholding
29th Oct 20071:01 pmRNSDividend
29th Oct 20077:01 amRNSFinal Results
16th Oct 20077:00 amRNSChange of Adviser
8th Oct 20077:00 amRNSNotice of Results
21st Aug 20079:32 amRNSAIM Rule 26 & Adviser Name
3rd Aug 20074:27 pmRNSDirector Declaration
6th Jul 20072:54 pmRNSNotifiable Interest
29th Jun 200711:44 amRNSBoard appointment-Replacement
29th Jun 20077:03 amRNSBoard appointment
27th Jun 20077:00 amRNSTrading Statement
30th Apr 20072:40 pmRNSTotal Voting Rights
27th Apr 20073:18 pmRNSNotifiable Interest
27th Apr 20073:16 pmRNSNotifiable Interest
27th Apr 20073:15 pmRNSNotifiable Interest
27th Apr 20073:14 pmRNSNotifiable Interest
11th Apr 20077:01 amRNSCompletion of assignment
20th Mar 20077:01 amRNSGrant of Patent
14th Mar 20073:52 pmRNSDividend Pay Date Amendment
19th Feb 20077:01 amRNSInterim Results
13th Feb 20077:01 amRNSNotice of Results
3rd Jan 20077:00 amRNSGrant of Patents
28th Dec 200610:30 amRNSTotal Voting Rights
8th Dec 20067:00 amRNSDirector/PDMR Shareholding
15th Nov 200611:59 amRNSAGM Statement
15th Nov 200611:55 amRNSResult of AGM
1st Nov 20067:01 amRNSDirector/PDMR Shareholding
24th Oct 20062:30 pmRNSDividend Declaration
23rd Oct 20067:01 amRNSFinal Results
12th Oct 20067:01 amRNSNotice of Results
29th Aug 20067:01 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.